Health3 days ago
Biopharma’s Fourth Quarter: Analysts Predict M&A Surge
The biopharma industry is entering a critical period as the fourth quarter of 2023 approaches, a time traditionally marked by increased mergers and acquisitions (M&A). Analysts...
